Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  FSD Pharma Inc    HUGE   CA35954B1076

FSD PHARMA INC

(HUGE)
SummaryQuotesChartsNewsCompany 
News SummaryMost relevantAll newsOfficial PublicationsSector news

FSD Pharma : Announces Holdings in Cannara Biotech Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/11/2019 | 04:27pm EDT

TORONTO, Jan. 11, 2019 /CNW/ - FSD Pharma ("FSD") announced today that, in connection with the business combination (the "Business Combination") completed on December 31, 2018 among Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) (the "Issuer"), Cannara Biotech Inc. and 11038427 Canada Inc., FSD Pharma, directly or indirectly, acquired ownership of 85,003,750 common shares ("Common Shares") of the Issuer, representing 12.25% of the issued and outstanding Common Shares of the Issuer.

FSD holds 75,003,750 of the Common Shares through its wholly-owned subsidiary, FV Pharma. The Common Shares are held in escrow in accordance with the rules of the Canadian Securities Exchange. Immediately prior to the completion of the Business Combination, FSD did not own or exercise control or direction over any securities of the Issuer.   

FSD holds and controls its Common Shares of the Issuer for investment purposes only and FSD may increase or decrease its beneficial ownership or control over the Common Shares of the Issuer, which it may do, subject to the terms of the escrow arrangements, from time to time, depending on market or other conditions and to the extent deemed advisable in light of its general investment strategy.

This news release is being disseminated as required by National Instrument 62-103 - The Early Warning System and Related Take-Over Bids and Insider Reporting Issues in connection with the anticipated filing of an early warning report (the "Early Warning Report"). A copy of the Early Warning Report will be available on SEDAR under the Issuer's issuer profile at www.sedar.com and can be obtained by contacting the Company as set out below.

SOURCE FSD Pharma Inc.

© Canada Newswire, source Canada Newswire English

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FSD PHARMA INC
07/02FSD PHARMA : Closes Deal to Acquire Prismic Pharmaceuticals
BU
06/27High Tide Upgrades Grasscity to Magento 2 ECommerce Platform
AQ
06/25FSD PHARMA : Receives Full 'Sale for Medical Purposes' Cannabis License from Hea..
AQ
06/24FSD PHARMA : Receives Full "Sale for Medical Purposes" Cannabis License from Hea..
AQ
06/24FSD PHARMA : Receives Full “Sale for Medical Purposes” Cannabis Lice..
BU
06/14FSD Pharma Continues to Add Expert Advisors Amid Buildout of Massive Facility..
NE
06/13FSD PHARMA : Adds Biotech/LifeSciences Industry veteran James A. Datin and Rober..
AQ
06/12FSD PHARMA : Adds Biotech/LifeSciences Industry veteran James A. Datin and Rober..
AQ
06/12FSD PHARMA : Adds Biotech/LifeSciences Industry veteran James A. Datin and Rober..
BU
06/06FSD PHARMA : Adds Two More Prominent Cannabis Researchers to Scientific Advisory..
AQ
More news
Chart FSD PHARMA INC
Duration : Period :
FSD Pharma Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Raza Bokhari Executive Co-Chairman & Chief Executive Officer
Anthony J. Durkacz Co-Chairman
Donal Carroll Chief Financial Officer
Vladimir Klacar Director
Gerald Goldberg Director
Sector and Competitors
1st jan.Capitalization (M$)
FSD PHARMA INC-52.63%161
CANOPY GROWTH CORP21.77%12 811
AURORA CANNABIS INC29.94%7 286
BEIJING TONGRENTANG CO., LTD.9.16%5 979
CRONOS GROUP INC28.72%5 074
DONG-E-E-JIAO CO LTD--.--%3 752